Study finds new pathway for treating non-alcoholic fatty liver disease
December 08, 2016, Erin Bluvas
Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham and Metabolon Inc. Research Triangle Park have discovered a new way to treat non-alcoholic fatty liver disease—a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure.